Omega 3 PUFA Market: Global Industry Analysis and Forecast (2023-2029)

Omega 3 PUFA Market is anticipated to reach US$ 1.96 Bn. by 2029 from US$ 1.50 Bn. in 2022 at a CAGR of 3.89% during a forecast period. Omega-3 Polyunsaturated Fatty Acids are a kind of polyunsaturated fatty acid that is utilized to strengthen the cardiovascular system. These chemicals can be found in both marine and botanical sources. Omega 3 PUFA is essential for anti-inflammatory activities in the cell membrane, which improves immunity in the face of any illness to the human body. With a 46.3 percent market share, North America led the way, followed by the APAC region. EPA has been the most important constituent type in Omega-3 polyunsaturated fatty acids, accounting for 64.7 percent of the total.Omega 3 PUFA MarketTo know about the Research Methodology:- Request Free Sample Report

Omega 3 PUFA Market Dynamics:

The market for Omega-3 PUFAs is growing as the frequency of cardiovascular illnesses rises. Unhealthy diets, cigarette use, and physical inactivity are only a few of the key causes of cardiovascular disease, which elevate blood pressure & blood glucose levels, resulting in overweight and obesity. According to the World Health Organization, the number of people dying from heart attacks and strokes is on the rise. As a result, the Omega-3 PUFA Market is expected to grow between 2022 and 2029. The market for Disposable Negative Pressure Wound Therapy Devices is growing due to the rising prevalence of chronic illnesses. Chronic illnesses are the major cause of death all over the world. Chronic illnesses are thought to be responsible for roughly 29% of all fatalities in the United States, with chronic diseases afflicting 40.5 percent of the population. As a result, the Disposable Negative Pressure Wound Therapy Devices Market is expected to grow between 2022 and 2029. Higher omega-3 PUFA prices and more competition are some of the factors that are expected to stymie the market's growth. During the forecast period 2022-2029, the market is expected to be hampered by stringent government restrictions and a lack of everyday use of nutritious items.

Omega 3 PUFA Market Segmentation Analysis:

By Type, The significant breakthroughs, such as emulsion and technologies like microencapsulation and stabilization, helped to overcome the problem of oxidation susceptibility, allowing EPA/DHA to be used in more food and beverage applications, particularly clear drinks. In fish oil formulations, the EPA is combined with DHA to treat a range of illnesses, including asthma, cancer, menstruation issues, hot flashes, hay fever, lung disorders, lupus erythematosus, and renal disease. The demand for EPA from infant formula, nutritional supplements, foods and drinks, and pharmaceutical sectors is increasing as a result of these health advantages, propelling the worldwide EPA/DHA market forward. ALA, on the other hand, is expected to expand at a faster rate than EPA/DHA throughout the forecast period, owing to rising demand for plant-based omega-3 PUFA from vegetarian and vegan customers throughout the world. Plant-derived omega-3 PUFA is expected to grow at the quickest rate in the market over the forecast period. The rising propensity of the vegetarian population to eat goods containing ingredients or components derived from plant sources is attributable to the rapid growth of this market. However, marine-sourced omega-3 PUFA held the largest share of the global omega-3 PUFA market in 2017, owing to factors such as its wide range of applications in dietary supplements and infant formula, approval from leading organizations for its use in various products, and its widespread availability and production. By Application, The gloabl Infant formula market is growing due to rising birth rates and parental buying power throughout the world. Infant formula is generally made from skimmed, processed cow's milk. The European Food Safety Authority (EFSA) has established that omega-3 fats, such as DHA and ALA, can help newborns' vision and cognition. In 2001, the US Food and Drug Administration allowed the use of DHA in baby formula, and now, the most popular formulas are DHA-fortified. Premature newborns and early infants can benefit from DHA-fortified formula.

Omega 3 PUFA Market Regional Insight:

In 2022, North America dominated the market, with a 35.3 percent share. This can be attributable to increased research and development as well as enhanced medicine penetration. The market in this area is growing due to rising dietary supplement usage, increased health advantages of omega-3 PUFA, rising healthcare spending, and improved healthcare infrastructure. In the Global Omega 3 PUFA Market, Asia Pacific is expected to grow at a high rate. The growing demand from consumers for foods with high fiber content is responsible for the market's size. Large expanses of farmland and production of high-fiber content plants and oilseeds, which are the key raw materials for fiber and specialty carbohydrate components, are found in emerging nations in this region, such as India and China. Due to changing client lives, the food business in the Asia-Pacific region is experiencing slow growth. The Asia-Pacific food and beverage market is now undergoing a dramatic shift as a result of growing urbanization, diet diversity, and increased foreign direct investment in the food sector. These are the factors that are likely to boost product sales.

Report Objectives:

Landscape analysis of the Omega 3 PUFA Market competitive benchmarking Past and current status of the industry with the forecasted market size and trends Evaluation of potential key players that include market leaders, followers, and new entrants Technology trends Potential impact of micro-economic factors of the market External and Internal factors affecting market have been analysed The report also helps in understanding the Omega 3 PUFA Market dynamics, structure by analysing the market segments and project the market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the market make the report investor’s guide.

Omega 3 PUFA Market Scope: Inquire before buying

Omega 3 PUFA Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.50 Bn
Forecast Period 2023 to 2029 CAGR: 3.89% Market Size in 2029: US $ 1.96 Bn
Segments Covered: by Type Docosahexaenoic acid (DHA) Eicosapentaenoic acid (EPA) Alpha linoleic acid (ALA)
by Source Marine Sources Fish oils Algal oils Krill oils Other Plant Source Flaxseed oil Chia Seed oil Other
by Application Dietary supplements Functional foods & beverages Pharmaceuticals Infant formula Others

Omega 3 PUFA Market, by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Omega 3 PUFA Market Key Players

1.Cargill Incorporated 2.FMC Corporation 3.Croda International PLC 4.Royal DSM 5.Omega Protein Corporation 6.Arista Industries Inc. 7.Denemoga 8.Polaris 9.Pharma Marine LLC. 10.GOED Omega 3 11.Croda International PLC 12.GC Rieber Oils 13.BASF SE 14.Pelagia AS 15.Koninklijke DSM NV 16.Arjuna Natural 17.Corbion NV 18.Archer Daniels Midland Company

Frequently Asked Questions

1. What is the projected market size & growth rate of Omega 3 PUFA Market? Ans- Omega 3 PUFA Market was valued at USD 1.50 billion in 2022 and is projected to reach USD 1.96 billion by 2029, growing at a CAGR of 3.89% during the forecast period. 2. What is the key driving factor for the growth of Omega 3 PUFA Market? Ans- The market for Omega-3 PUFAs is growing as the frequency of cardiovascular illnesses rises. 3. Which Region accounted for the largest market share? Ans- In 2021, North America dominated the market, with a 35.3 percent share. 4. What makes North America a Lucrative Market for Omega 3 PUFA Market? Ans- This can be attributable to increased research and development as well as enhanced medicine penetration. 5. What are the top players operating in Omega 3 PUFA Market? Ans- Cargill Incorporated, FMC Corporation, Croda International PLC, Royal DSM, Omega Protein Corporation, and Arista Industries Inc.
1. Global Omega 3 PUFA Market: Research Methodology 2. Global Omega 3 PUFA Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Omega 3 PUFA Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Omega 3 PUFA Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Omega 3 PUFA Market Segmentation 4.1 Global Omega 3 PUFA Market, By Type (2022-2029) • Docosahexaenoic acid (DHA) • Eicosapentaenoic acid (EPA) • Alpha linoleic acid (ALA) 4.2 Global Omega 3 PUFA Market, By Treatment (2022-2029) • Marine Sources o Fish oils o Algal oils o Krill oils o Other • Plant Source o Flaxseed oil o Chia Seed oil o Other 4.3. European Omega 3 PUFA Market, By End-user (2022-2029) • Dietary supplements • Functional foods & beverages • Pharmaceuticals • Infant formula • Others 5. North America Omega 3 PUFA Market (2022-2029) 5.1 North American Omega 3 PUFA Market, By Type (2022-2029) • Docosahexaenoic acid (DHA) • Eicosapentaenoic acid (EPA) • Alpha linoleic acid (ALA) 5.2 North America Omega 3 PUFA Market, By Treatment (2022-2029) • Marine Sources o Fish oils o Algal oils o Krill oils o Other • Plant Source o Flaxseed oil o Chia Seed oil o Other 5.3. European Omega 3 PUFA Market, By End user (2022-2029) • Dietary supplements • Functional foods & beverages • Pharmaceuticals • Infant formula • Others 5.4 North America Paediatric Healthcare Market, by Country (2022-2029) • United States • Canada • Mexico 6. Asia Pacific Omega 3 PUFA Market (2022-2029) 6.1. Asia Pacific Omega 3 PUFA Market, By Type (2022-2029) 6.2. Asia Pacific Omega 3 PUFA Market, By Treatment (2022-2029) 6.3. European Omega 3 PUFA Market, By End user (2022-2029) 6.4. Asia Pacific Omega 3 PUFA Market, by Country (2022-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Omega 3 PUFA Market (2022-2029) 7.1. Middle East and Africa Omega 3 PUFA Market, By Type (2022-2029) 7.2. Middle East and Africa Omega 3 PUFA Market, By Treatment (2022-2029) 7.3. European Omega 3 PUFA Market, By End user (2022-2029) 7.4. Middle East and Africa Omega 3 PUFA Market, by Country (2022-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Omega 3 PUFA Market (2022-2029) 8.1. Latin America Omega 3 PUFA Market, By Type (2022-2029) 8.2. Latin America Omega 3 PUFA Market, By Treatment (2022-2029) 8.3. European Omega 3 PUFA Market, By End user (2022-2029) 8.4 Latin America Omega 3 PUFA Market, by Country (2022-2029) • Brazil • Argentina • Rest Of Latin America 9. European Omega 3 PUFA Market (2022-2029) 9.1. European Omega 3 PUFA Market, By Type (2022-2029) 9.2. European Omega 3 PUFA Market, By Treatment (2022-2029) 9.3. European Omega 3 PUFA Market, By End user (2022-2029) 9.4 European Omega 3 PUFA Market, by Country (2022-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Cargill Incorporated 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Cargill Incorporated 10.3. FMC Corporation 10.4. Croda International PLC 10.5. Royal DSM 10.6. Omega Protein Corporation 10.7. Arista Industries Inc. 10.8. Denemoga 10.9. Polaris 10.10. Pharma Marine LLC. 10.11. GOED Omega 3 10.12. Croda International PLC 10.13. GC Rieber Oils 10.14. BASF SE 10.15. Pelagia AS 10.16. Koninklijke DSM NV
  • INQUIRE BEFORE BUYING